Synaptogyrin-3 Prevents Cocaine Addiction and Dopamine Deficits

Emily Grace Peck,Katherine M. Holleran,Alyson M Curry,Kimberly Marie Holter,Paige Estave,Jonathon P Sens,Jason Locke,Olivia Ortelli,Brianna George,Monica Dawes,Alyssa M West,Nancy Alexander,Drew Kiraly,Sean Farris,Robert Warren Gould,Brian McCool,Sara R Jones
DOI: https://doi.org/10.1101/2024.07.27.605436
2024-07-29
Abstract:Synaptogyrin-3, a functionally obscure synaptic vesicle protein, interacts with vesicular monoamine and dopamine transporters, bringing together dopamine release and reuptake sites. Synaptogyrin-3 was reduced by chronic cocaine exposure in both humans and rats, and was inversely correlated with motivation to take cocaine in rats. Synaptogyrin-3 overexpression in dopamine neurons reduced cocaine self-administration, decreased anxiety-like behavior, and enhanced cognitive flexibility. Overexpression also enhanced nucleus accumbens dopamine signaling and prevented cocaine-induced deficits, suggesting a putative therapeutic role for synaptogyrin-3 in cocaine use disorder.
Biology
What problem does this paper attempt to address?